Set therapy goals in treating pituitary-dependent hyperadrenocorticism in dogs
Apr 1, 2006
By:
Johnny D. Hoskins, DVM, PhD, Dipl. ACVIM
Reduction in appetite indicates that the induction phase of therapy has been completed.
|
Feb 1, 2006
By:
Johnny D. Hoskins, DVM, PhD, Dipl. ACVIM
Canine hemangiosarcoma (HSA) is an incurable tumor of vascular endothelial cells. HSA accounts for 7 percent of all cancers; thus, of the 65 million pet dogs living in the United States today, between 1.5 million and 2.5 million could get HSA and succumb to it. Although dogs of any age and breed are susceptible to HSA, it occurs more commonly in dogs beyond middle age and in breeds such as Golden Retrievers, German Shepherds, Portuguese Water Dogs and Skye Terriers. The estimated life-time risk of HSA in Golden Retrievers is one in five, illustrating the magnitude of this problem.
|
Dec 1, 2005
By:
Johnny D. Hoskins, DVM, PhD, Dipl. ACVIM
Pathologic processes, such as inflammatory mass and neoplasia, share some MRI characteristics as well as similarities in origin, shape or anatomic site.
|
Canine IBD seems to vary in its clinical presentation, natural course, response to treatment and prognosis
Nov 1, 2005
By:
Johnny D. Hoskins, DVM, PhD, Dipl. ACVIM
Diet modifications, antibiotic treatment, and specific antiinflammatories and immunosuppressives can treat IBD.
|
Oct 1, 2005
By:
Johnny D. Hoskins, DVM, PhD, Dipl. ACVIM
Dr. Deborah Silverstein at the 2005 American College of Veterinary Internal Medicine Forum in Baltimore gave a lecture on shock fluid therapy. Some relevant points in this lecture are provided below.
|
Aug 1, 2005
By:
Johnny D. Hoskins, DVM, PhD, Dipl. ACVIM
Antimicrobial selection should strive for a spectrum that is as narrow as possible, thus avoiding the sequelae of drug use on the normal flora and unnecessary selection pressure.
|
|
Featuring Information from:
